Language selection

Search

Details for: MINT-SERTRALINE

Company: MINT PHARMACEUTICALS INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02402378MINT-SERTRALINESERTRALINE (SERTRALINE HYDROCHLORIDE)25 MGCAPSULEORAL
02402394MINT-SERTRALINESERTRALINE (SERTRALINE HYDROCHLORIDE)50 MGCAPSULEORAL
02402408MINT-SERTRALINESERTRALINE (SERTRALINE HYDROCHLORIDE)100 MGCAPSULEORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) - Assessing the Potential Risk of Autism
Summary Safety Review - Antidepressants - Assessing the Potential Risk of Serious Eye Disorder (Angle-Closure Glaucoma)
Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-norepinephrine Reuptake Inhibitors (SNRIs) - Assessing the Potential Risk of Sexual Dysfunction despite Treatment Discontinuation

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: